期刊文献+

从1例顺铂联合培美曲塞化疗致Ⅳ度呕吐病例中分析止吐药的合理应用 被引量:3

Analysis of vomiting of type Ⅳ caused by chemotherapy of cisplatin combined with pemetrexed
下载PDF
导出
摘要 肿瘤患者化疗导致的呕吐现象是一种常见的不良反应,可以通过合理用药来提前预防或控制症状,减轻痛苦。本文通过对1例高致吐化疗药顺铂联合培美曲塞化疗致Ⅳ度呕吐的病例分析,详细介绍了该患者与呕吐相关的治疗过程,讨论了引起严重恶心呕吐的原因,分析了预防和解救呕吐状况的给药方案,并提出了改善患者呕吐症状的预防给药建议。 It is one of common adverse reactions that tumor patients vomits after chemotherapy, which can be prevented or controlled with rational use of drugs to relieve their pain. This paper outlined a case of vomiting of type Ⅳ caused by chemotherapy of cisplatin, a highly vomitive chemotherapeutic drug, combined with pemetrexed, and it described the treatment process associated with vomiting. We discussed the causes of severe nausea and vomiting, and analysed the drug regimen of vomiting prevention and treatment. Lastly, we gave proposal of prevention medicine to improve the patient's symptoms of vomiting of type Ⅳ.
作者 陆国忠 裴蕾
机构地区 解放军第
出处 《中南药学》 CAS 2016年第4期440-442,共3页 Central South Pharmacy
关键词 化疗 呕吐 顺铂 培美曲塞 止吐药 chemotherapy vomiting cisplatin pemetrexed antiemetic
  • 相关文献

参考文献14

  • 1林千鹤子,韩少良.抗癌药物毒副反应的对策[J].日本医学介绍,2001,22(11):491-493. 被引量:59
  • 2NCCN Clinical pratice Guidelines in Oncology.Antiemesis[S].2015.
  • 3林清强,叶锦林.新型5-HT3受体拮抗剂帕洛诺司琼[J].中国科技信息,2005(11):157-157. 被引量:12
  • 4Massaro AM,Lenz KL Aprepitant.A novel antien etic for then otherapy induced nausea and vomiting[J].Ann Pharmacother,2005,39(1):77-85.
  • 5Hesketh PJ,Van Belle S,Aapro M,et al.Differential involvement of neurotrans mitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists[J].Eur J Cancer,2003,39(8):1074-1080.
  • 6Poli-Bigelli S,Rodrigues-Pereira J,Carides AD,et al.Addition of the neurokin in 1 receptor an tagonist aprepitant to standard an tiemetic therapy improves control of chemotherapy induced nausea and vomiting.Results from a randomized,double blind,placebo controlled trial in Latin America[J].Cancer,2003,97(12):3090-3098.
  • 7Hesketh PJ,Grunberg SM,G ralla RJ,et al.The oral neurok in inlantagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting:Amultinational randomized,double blind,placebo controlled trial in patients receiving high dose cisplatin The Aprepitant Protocol052 Study Group[J].J Clin Oncol,2003,21(22):4112-4119.
  • 8Herrington JD,Jaskiewicz AD,Song J.Randomized,placebo controlled,pilot study evaluating aprepitants ingle dose plus palonosetron and dexamethas one for the prevention of acute and delayed chemotherapy induced nausea and vomiting[J].Cancer,2008,112(9):2080-2087.
  • 9方振威,翟所迪.阿瑞吡坦防治化疗致恶心呕吐的Meta分析[J].北京大学学报(医学版),2010,42(6):756-763. 被引量:18
  • 10无,于世英,印季良,秦叔逵,王杰军,陈元,沈琳,徐建国,谢广茹,张力,樊旼,陈映霞,周彩存,徐兵河,徐瑞华,王洁,胡夕春,马军,程颖,李进,冯继锋,高雨农,黄诚,侯梅,梁军,廖宁,刘巍,王哲海,肖穗君,房澍名,龚新雷,吴穷,王琳,王耀.肿瘤治疗相关呕吐防治指南(2014版)[J].临床肿瘤学杂志,2014,19(3):263-273. 被引量:364

二级参考文献68

  • 1胡凯,丁鼎乐.帕洛诺司琼市场前景看好[J].上海医药,2004,25(11):518-518. 被引量:8
  • 2杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 3张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:128
  • 4陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 5Hiekok JT,Roscoe JA,Morrow GR,et al.Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics:a University of Rochester James P.Wilmot Cancer Center Community Clinical Oneology Program Study of 360 cancer patients treated in the community[J].Cancer,2003,97(11):2880-2886.
  • 6Jordan K,Schmoll HJ,Aapro MS.Compamtive activity ofantiemetic drugs[J].Crit Rev oncol Hematol,2007,61(2):162-175.
  • 7Grunberg SM,Deuson RR,Mavros P.et al.Incidence of chemotherapy-induced nausea and emesis after modern antiemetics[J].Cancer,2004,100(10):2261-2268.
  • 8Massaro AM,Lenz KL.Aprepitant:A novel antiemetic for chemotherapy-induced nausea and vomiting[J].Ann Pharmacother,2005.39(1):77-85.
  • 9Warr DG,Hesketh PJ,Gralla RJ.et al.Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenie chemotherapy[J].J Clin Oneol,2005,23(12):2822-2830.
  • 10National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:Antiemesis,2nd,2010[M/OL].(2010-07-04)[2010-08-10].http://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf.

共引文献464

同被引文献15

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部